HeraMED Limited

A$0.04As of Sun 8 Nov 2026, 12:00 UTC
ASX:HMDHealthcare
Country Australia
PE (Fwd) •••
TSR 8Y CAGR (16.77%)
Div yield —
ROE (223.73%)
Medical Devices
Beta (5Y) 0.18
PE TTM —
TSR TTM 2.78%
Mkt cap A$42.87M
ROIC (143.59%)
SE Grade™
Value
Quality
Moat
Consensus
Reference
$0.047
27.10%
192.71%
Hold 0|8|4|7|2
4Q25
1Q26
2Q26
3Q26
Earnings per share$
—
—
—
—
5.35%
16.09%
20.88%
28.72%
Revenue$M
3.101
3.061
2.986
2.969
4.10%
2.65%
1.63%
0.51%
Peers (US$29.44M)
Cap (US$)
PE
32.93M
240.2x
Capital
TTM
5Y
10Y
Leveragex
0.111
0.352
0.374
EBIT/Intx
2.035
1.215
0.873
Own earn%
413.87
(65.70)
(73.10)
Sh yield%
34.35
18.55
20.35
Owners
Insiders/Inst%
3.67
42.27
Short interest%
3.23
SBC / revenue%
2.65
Record
10Y
Profitable years
10/10
Revenue growth years
10/10
EPS growth years
10/10
Dividend streakyrs
13
Op margin range%
7–16
$1 testx
−0.1
Incr. ROIC%
8